EQUILLIUM, INC.

Transcripts Equillium, Inc.

Equities

EQ

US29446K1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
0.801 ^USD	-10.69%		-46.60%	+10.79%

Jun. 04	Equillium, Inc. Announces Topline Data from Its Phase 2, Single Dose, Proof-Of-Concept Study of Eq101	CI
May. 14	Equillium, Inc. Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Equillium, Inc. - Analyst/Investor Day	23-10-16
Transcript : Equillium, Inc. - Shareholder/Analyst Call	22-12-06
Transcript : Equillium, Inc. - Special Call	22-09-27
Transcript : Equillium, Inc., Metacrine, Inc. - M&A Call	22-09-07
Transcript : Bioniz Therapeutics, Inc., Equillium, Inc. - M&A Call	22-02-16
Transcript : Equillium, Inc. Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM	21-03-09
Transcript : Equillium, Inc. Presents at SVB Leerink 10th Annual Global Healthcare Conference 2021, Feb-25-2021 11:20 AM	21-02-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer